159 related articles for article (PubMed ID: 15047977)
1. Are glycineB sites involved in the development of morphine tolerance?
KotliĆska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
2. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
3. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614.
Tiseo PJ; Inturrisi CE
J Pharmacol Exp Ther; 1993 Mar; 264(3):1090-6. PubMed ID: 8450453
[TBL] [Abstract][Full Text] [Related]
4. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.
Kest B; Mogil JS; Shamgar BE; Kao B; Liebeskind JC; Marek P
Proc West Pharmacol Soc; 1993; 36():307-10. PubMed ID: 8378393
[No Abstract] [Full Text] [Related]
5. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
6. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.
Popik P; Kozela E
Pol J Pharmacol; 1999; 51(3):223-31. PubMed ID: 10600036
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor antagonist MK-801 suppresses glial pro-inflammatory cytokine expression in morphine-tolerant rats.
Liu CH; Cherng CH; Lin SL; Yeh CC; Wu CT; Tai YH; Wong CS
Pharmacol Biochem Behav; 2011 Sep; 99(3):371-80. PubMed ID: 21624390
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
9. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
[TBL] [Abstract][Full Text] [Related]
11. Involvement of N-methyl-D-aspartate receptors and nitric oxide in the rostral ventromedial medulla in modulating morphine pain-inhibitory signals from the periaqueductal grey matter in rats.
Javanmardi K; Parviz M; Sadr SS; Keshavarz M; Minaii B; Dehpour AR
Clin Exp Pharmacol Physiol; 2005 Jul; 32(7):585-9. PubMed ID: 16026519
[TBL] [Abstract][Full Text] [Related]
12. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
13. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
[TBL] [Abstract][Full Text] [Related]
14. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
Lutfy K; Doan P; Weber E
Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
[TBL] [Abstract][Full Text] [Related]
15. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
Craft RM; Lee DA
Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
[TBL] [Abstract][Full Text] [Related]
16. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate.
Hasanein P; Parviz M; Keshavarz M; Javanmardi K; Allahtavakoli M; Ghaseminejad M
Eur J Pharmacol; 2007 Jan; 554(2-3):123-7. PubMed ID: 17107671
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]